Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Here’s What Happened

Anbio Biotechnology (NASDAQ:NNNN) shares gapped down prior to trading on Friday . The stock had previously closed at $22.54, but opened at $21.51. Anbio Biotechnology shares last traded at $21.6190, with a volume of 11,484 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, February 9th. One analyst has rated the stock with a Hold rating, According to MarketBeat, Anbio Biotechnology currently has an average rating of “Hold”.

Anbio Biotechnology Trading Down 9.4%

Anbio Biotechnology (NASDAQ:NNNN) last released its quarterly earnings data on Tuesday, December 30th. The company reported $0.04 EPS for the quarter. The firm had revenue of $2.29 million during the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.